FDA needs a victory all they have been doing is ap
Post# of 148187
Conv Plasma - study stopped no Benefit for Severe critical Covid-19 patients. Nothing available for severe critical to reduce mortality. The world will need a stock pile of leronlimab.
Leronlimab will be New supercharged improved SOC.
https://www.usatoday.com/story/news/health/20...901125002/